HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease - Wikidata - awgldk - TriplyDB

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

http://www.wikidata.org/entity/Q28267375

about

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells HIV type-1 infection of the cotton rat (Sigmodon fulviventer and S. hispidus)Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1 Human herpesvirus 6 Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B Apoptosis of uninfected cells induced by HIV envelope glycoproteins Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats The immunological synapse: the gateway to the HIV reservoir Natural SIV hosts: showing AIDS the door Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes.Release of virus from lymphoid tissue affects human immunodeficiency virus type 1 and hepatitis C virus kinetics in the blood.ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans The Dynamics of T and B Cells in Lymph Node during Chronic HIV Infection: TFH and HIV, Unhappy Dance Partners?Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide Dissecting How CD4 T Cells Are Lost During HIV Infection Characterizing follicular dendritic cells: A progress report Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication.Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected mice Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein Compounds that target novel cellular components involved in HIV-1 transcription Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites Novel inhibitory effects of gamma-glutamylcysteine ethyl ester against human immunodeficiency virus type 1 production and propagation.Grifonin-1: a small HIV-1 entry inhibitor derived from the algal lectin, Griffithsin Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy Preclinical pharmacokinetics and distribution to tissue of AG1343, an inhibitor of human immunodeficiency virus type 1 protease Why can't cytotoxic T cells handle HIV?Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages.Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy.

P2860

Q22242965-051CE5EC-F53A-449B-A835-54E7BE6BF119 Q22251087-2FB77B71-FB9E-4737-88F6-05077736C8F1 Q24324378-3443760B-10FD-4704-B91E-604A13B8D140 Q24568326-CA330C09-18A4-4CBF-97B8-3318F3C0C483 Q24647800-615F604D-0310-4A97-AE80-FEB3DFF99C72 Q24648628-73A23B8C-84D3-4A96-AAC8-74952B98C574 Q24649124-00CD3A7B-55D9-486B-A940-6FB53D52D4EA Q24651142-712ACFDD-6E06-4B4A-9C7D-B1B5753A09BA Q24651506-E1CBBAFC-6BF8-4398-B704-E50367EFEBAF Q24654984-889C440F-C343-451B-96B0-36061480ADE9 Q24682560-C308FEB8-FA84-4D48-A259-541A0A6E2573 Q24683663-9DB1DD2F-8E2D-4172-85FD-CBBD32F7F18C Q24685157-447112F0-8309-4198-B0CE-AF857DD0279F Q24801374-CED57993-35B9-4151-BAE0-4C10FB679166 Q26858837-6CF48F6F-6CE0-45B8-8E19-EC5884C09AE7 Q27002959-43BE2F45-962A-47A0-A7CF-39C860D8779F Q27026135-2B9AB005-41A1-40DF-BAEB-F2EE3E599DB6 Q27316160-D783EABD-C4A7-4298-8694-7E1AF44662B0 Q27469994-6A0B3505-0964-4315-946C-6D90535D73D2 Q27729982-CEEAE0FF-6A76-4821-9CCB-364E04B48DDC Q28067520-E3CF7D8A-9699-4CAF-BC6E-494590F36BFA Q28238899-9B0230DD-8D73-4BA7-AFAC-AE0B8584C59E Q28274045-26C07D58-3DAA-4A12-83D4-CCD9833BBB9D Q28293692-23420B4A-CAC7-4E1A-94A2-00BD8B73A50E Q28343701-6A40103E-9972-4384-AFD3-439F38E17CEE Q28344926-2491A465-135A-4E48-A77C-D4B59B9EB9ED Q28367526-BB319A41-1ECB-4E27-96E0-7D9460DDE8D2 Q28368058-0DBEBE48-D601-4CB9-A762-8F246EE366C1 Q28369082-C45F6F6E-C46D-4701-8EDE-A86E5C5CDD6F Q28369100-5747988C-F6DE-4A66-959B-1CDD3C20CB73 Q28378815-44A95C37-F064-49D4-8DEC-F0EA8A7A3811 Q28379086-D6F63DFB-62CB-445E-BC00-B317894B4F0D Q28379516-60455630-456C-4214-99B0-D6AA4A2C3D5E Q28744163-43A67870-2DA3-4C33-A9A4-98C34CDBB8BE Q29615993-B8B88080-8BBB-4A2F-8367-FE2B11F3209D Q29616404-CA97F725-EBB6-4F7F-BE00-CA5774946C99 Q30425015-E6F94419-1595-43F4-9945-D621943A0799 Q30453955-74237D9D-B381-4FE1-9583-89B6F53336CF Q33315307-67AB31D5-8AA0-47BC-8DE1-808FB7BC3CC9 Q33547148-7B1DC259-1251-4724-A07D-704308AE5D43

P2860

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

http://www.wikidata.org/entity/Q28267375

description

1993 nî lūn-bûn

@nan

1993 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի մարտին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

HIV infection is active and pr ...... ically latent stage of disease

@ast

HIV infection is active and pr ...... ically latent stage of disease

@en

HIV infection is active and pr ...... ically latent stage of disease

@nl

type

label

HIV infection is active and pr ...... ically latent stage of disease

@ast

HIV infection is active and pr ...... ically latent stage of disease

@en

HIV infection is active and pr ...... ically latent stage of disease

@nl

prefLabel

HIV infection is active and pr ...... ically latent stage of disease

@ast

HIV infection is active and pr ...... ically latent stage of disease

@en

HIV infection is active and pr ...... ically latent stage of disease

@nl

P1433

Q28267375-8F1D4EC4-06F1-43CA-A4FA-27B7F35C8471

P1476

Q28267375-C1FA869A-861F-45C4-9C2F-C0350AB01007

P2093

Q28267375-041C4001-3CCB-4C00-B95C-819A05BF6B50

Q28267375-09E332EF-33AA-411A-B44C-846507863521

Q28267375-1A243580-806E-4BA5-8A2B-75D0A0ED4ECC

Q28267375-48974DC8-623C-4894-B86B-623130249F91

Q28267375-6AA0C8FC-36F0-4CD4-AC8C-68DCBD5CD95C

Q28267375-6C5FBA03-EE76-4CAA-8E2D-6A1A4CFFF92B

Q28267375-8E1BC64D-A319-4984-A32B-B79CF2961853

Q28267375-F239C3DA-394A-4EDD-A0CD-92A8918D58B3

P2888

Q28267375-77191386-ED51-4E21-93C7-9A0BC239AE9F

P304

Q28267375-961C0B19-F0B5-4F18-A580-6E5BAAB003D3

P31

Q28267375-D395E162-F0BC-4F6C-B13F-8D81C3395B7C

P3181

Q28267375-3F63FE9E-5BDE-4BD9-8EA3-4A91571B08BD

P356

Q28267375-EC76D04C-610A-4C91-A421-E47568E322DC

P407

Q28267375-C7187B53-C45A-42B2-97AB-AF3993A42340

P433

Q28267375-AAF7C431-2356-4F04-BE45-E03D4E8A0C3D

P478

Q28267375-FD671366-BB66-4A11-98CD-7AF12859B09D

P50

Q28267375-9333FED6-9914-4704-9FA3-4E8E0B4D9741

P577

Q28267375-D9398A0D-C89F-45A6-A6E3-0DA7745AB2F4

P6179

Q28267375-EE1A1843-836B-48ED-A573-D2AEE9BC8B69

P698

Q28267375-7CD647FD-4DA0-4DDA-BFE3-8B338D03E436

P921

Q28267375-69AB0660-7716-46C5-A818-218DEFB12E0C

P3181

P356

P1433

P1476

HIV infection is active and pr ...... ically latent stage of disease

@en

P2093

C Graziosi

http://www.w3.org/2001/XMLSchema#string

C H Fox

http://www.w3.org/2001/XMLSchema#string

D P Kotler

http://www.w3.org/2001/XMLSchema#string

G Pantaleo

http://www.w3.org/2001/XMLSchema#string

J F Demarest

http://www.w3.org/2001/XMLSchema#string

J M Orenstein

http://www.w3.org/2001/XMLSchema#string

L Butini

http://www.w3.org/2001/XMLSchema#string

M Montroni

http://www.w3.org/2001/XMLSchema#string

P2888

P304

355-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1528743

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/362355A0

http://www.w3.org/2001/XMLSchema#string

P407

P433

6418

http://www.w3.org/2001/XMLSchema#string

P478

362

http://www.w3.org/2001/XMLSchema#string

P50

P577

1993-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1041590783

http://www.w3.org/2001/XMLSchema#string

P698

8455722

http://www.w3.org/2001/XMLSchema#string

P921